Syros Pharmaceuticals Inc. (SYRS) at a glance

Syros Pharmaceuticals Inc. (SYRS) is a micro-cap Healthcare company. It trades at $0, with a P/E of 6.5 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Value (92/100) and its weakest is Growth (10/100). Its volatility is roughly in line with the market.

Price

$0.00

Market cap

$2,683

P/E ratio

6.5

Dividend yield

None

Beta

1.27

52-week range

$0.00 to $0.04